Caplight Directory>Investors>National Center for Advancing Translational Sciences>National-center-for-advancing-translational-sciences


National Center for Advancing Translational Sciences

National Center for Advancing Translational Sciences

Bethesda, Marylandncats.nih.gov

Overview

The National Center for Advancing Translational Sciences (NCATS) is one of 27 institutes and centers of the U.S. National Institutes of Health (NIH). Its mission is to transform scientific discoveries into new treatments and cures for disease that can be delivered faster to patients. The center focuses on what is common across diseases and the translational process, studying it as a scientific and operational problem. NCATS provides funding and resources through grants, prize competitions, and collaborations with the public and private sectors to reduce, remove, or bypass bottlenecks in the translational research pipeline.

Portfolio Companies

19

Investments

CompanyDateStageLead
Neucore BioSep 2025GrantCo-investor
CILA TherapeuticsAug 2025GrantCo-investor
Phrase HealthAug 2024GrantCo-investor
Rejuvenation TechnologiesAug 2024GrantCo-investor
Cellular VehiclesJun 2024GrantCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBethesda, Maryland
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.